Table 2.
Worldwide deaths and rates by sex for the 29 cancer types in 2019 in adults over 75 years old and the change in the trends from 1990 to 2019
| both | Male | Female |
1990–2019 EAPC No. (95% CI) |
||||
|---|---|---|---|---|---|---|---|
| Case | Rate per 100,000 | Case | Rate per 100,000 | Case | Rate per 100,000 | ||
| Total cancer | 3,487,482 | 1260.90 | 1,923,318 | 1667.95 | 1,564,164 | 969.86 | -0.05 (0.07 ~ -0.16) |
| Lung cancer | 701,015 | 253.45 | 445,168 | 386.06 | 255,847 | 158.64 | 0.68 (0.95 ~ 0.42) |
| Colon and rectum cancer | 468,185 | 169.27 | 226,604 | 196.52 | 241,581 | 149.79 | 0.01 (0.33 ~ -0.31) |
| Stomach cancer | 346,650 | 125.33 | 199,465 | 172.98 | 147,185 | 91.26 | -1.1 (-0.82 ~ -1.48) |
| Prostate cancer | 308,160 | 111.41 | 308,160 | 267.24 | – | – | -0.32 (0.07 ~ -0.70) |
| Pancreatic cancer | 205,547 | 74.32 | 89,873 | 77.94 | 115,675 | 71.72 | 0.10 (1.52 ~ 0.48) |
| Breast cancer | 182,595 | 66.02 | 3410 | 2.96 | 179,186 | 111.10 | -0.48 (0.01 ~ -0.97) |
| Esophageal cancer | 156,277 | 56.50 | 101,739 | 88.23 | 54,538 | 33.82 | -0.45 (0.07 ~ -0.97) |
| Liver cancer | 139,039 | 50.27 | 80,105 | 69.47 | 58,935 | 36.54 | -0.54 (0.031 ~ -1.10) |
| Bladder cancer | 125,997 | 45.55 | 89,449 | 77.57 | 36,548 | 22.66 | -0.27 (0.34 ~ -0.87) |
| Leukemia | 98,229 | 35.51 | 52,845 | 45.83 | 45,384 | 28.14 | -0.05 (0.63 ~ -0.74) |
| Non-Hodgkin lymphoma | 88,570 | 32.02 | 44,157 | 38.29 | 44,413 | 27.54 | 0.31 (1.06 ~ -0.43) |
| Gallbladder and biliary | 74,599 | 26.97 | 29,795 | 25.84 | 44,804 | 27.78 | -0.36 (0.42 ~ -1.13) |
| Kidney cancer | 61,620 | 22.28 | 36,019 | 31.24 | 25,601 | 15.87 | 1.05 (1.98 ~ 0.12) |
| Ovarian cancer | 52,315 | 18.91 | – | – | 52,315 | 32.44 | -0.31 (0.61 ~ -1.23) |
| Lip and oral cavity cancer | 49,820 | 18.01 | 26,858 | 23.29 | 22,962 | 14.24 | 0.37 (1.39 ~ -0.64) |
| Cervical cancer | 48,158 | 17.41 | – | – | 48,158 | 29.86 | -0.91 (0.02 ~ -1.82) |
| Multiple myeloma | 45,876 | 16.59 | 22,733 | 19.71 | 23,144 | 14.35 | 0.23 (1.26 ~ -0.79) |
| Brain and central nervous | 44,701 | 16.16 | 21,684 | 18.81 | 23,017 | 14.27 | 1.09 (2.18 ~ 0.00) |
| Non-melanoma skin cancer | 30,240 | 10.93 | 16,243 | 14.09 | 13,997 | 8.68 | 0.92 (2.27 ~ -0.41) |
| Uterine cancer | 29,990 | 10.84 | – | – | 29,990 | 18.60 | -0.75 (0.42 ~ -1.91) |
| Larynx cancer | 28,527 | 10.31 | 23,509 | 20.39 | 5018 | 3.11 | -0.74 (0.49 ~ -1.96) |
| Malignant skin melanoma | 22,378 | 8.09 | 11,604 | 10.06 | 10,774 | 6.68 | 0.46 (1.95 ~ -1.01) |
| Other pharynx cancer | 20,239 | 7.32 | 14,369 | 12.46 | 5870 | 3.64 | 1.02 (2.71 ~ -0.64) |
| Thyroid cancer | 16,561 | 5.99 | 6329 | 5.49 | 10,232 | 6.34 | 0.22 (1.94 ~ -1.47) |
| Mesothelioma | 11,680 | 4.22 | 8791 | 7.62 | 2889 | 1.79 | 0.41 (2.48 ~ -1.62) |
| Nasopharynx cancer | 10,145 | 3.67 | 6442 | 5.59 | 3703 | 2.30 | -0.88 (1.19 ~ -2.91) |
| Hodgkin lymphoma | 4364 | 1.58 | 2288 | 1.98 | 2076 | 1.29 | -1.95 (0.96 ~ -4.78) |
| Testicular cancer | 1254 | 0.45 | 1254 | 1.09 | – | – | 0.07 (6.70 ~ -6.14) |
| Other malignant neoplasms | 114,750 | 41.49 | 54,423 | 47.20 | 60,326 | 37.41 | 0.13 (0.78 ~ -0.51) |
EAPC estimated annual percentage change